Aquatic Capital Management’s Regenxbio RGNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$527K Buy
+43,998
New +$365K 0.02% 774
2025
Q4
– Sell
-3,806
Closed -$36.7K – 1711
2025
Q3
$36.7K Buy
+3,806
New +$33.7K ﹤0.01% 1297
2024
Q3
– Sell
-2,600
Closed -$30.4K – 1477
2024
Q2
$30.4K Buy
+2,600
New +$40.5K ﹤0.01% 1062
2023
Q4
– Sell
-4,100
Closed -$67K – 1574
2023
Q3
$67K Buy
+4,100
New +$74.3K ﹤0.01% 908
2023
Q2
– Sell
-5,300
Closed -$100K – 1684
2023
Q1
$100K Buy
+5,300
New +$117K 0.01% 750
2022
Q4
– Sell
-22,500
Closed -$595K – 1751
2022
Q3
$595K Buy
+22,500
New +$668K 0.06% 372

Other funds holding RGNX

Aquatic Capital Management's RGNX Position: Q2 2026 in Review

Aquatic Capital Management opened a new position in Regenxbio (RGNX) in Q2 2026: 43,998 shares worth $527K. The stake represents 0.02% of the portfolio and ranks #774 among its holdings. This is a return to the name: Aquatic Capital Management previously reported a position in RGNX as recently as Q3 2025.

Aquatic Capital Management first reported a position in RGNX in Q3 2022 and has held it in 6 quarters since. The position peaked at $595K in Q3 2022. 165 funds tracked by Wall St. Rank hold RGNX as of Q2 2026.

  • Aquatic Capital Management held 43,998 shares of Regenxbio worth $527K as of Q2 2026.
  • Regenxbio was a new Aquatic Capital Management position in Q2 2026.
  • Regenxbio made up 0.02% of Aquatic Capital Management's portfolio in Q2 2026, its #774 holding.
  • Aquatic Capital Management first reported a position in Regenxbio in Q3 2022 and has held it in 6 quarters since.
  • Aquatic Capital Management's Regenxbio position peaked at $595K in Q3 2022.
  • 165 funds tracked by Wall St. Rank held Regenxbio as of Q2 2026.

Based on Aquatic Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.